Risk of port-site metastases in pelvic cancers after robotic surgery

Eur J Surg Oncol. 2015 Apr;41(4):599-603. doi: 10.1016/j.ejso.2015.01.003. Epub 2015 Jan 16.

Abstract

Objective: To assess the risk of occurrence of port-site metastases after robotic surgery for pelvic cancer.

Methods: Retrospective study from June 2007 to March 2013 of patients with gynecologic cancer who underwent robot-assisted surgery. We collected preoperative data, including characteristics of patients and FIGO stage, intraoperative data (surgery performed, number of ports), and postoperative data (occurrence of metastases, occurrence of port-site metastases).

Results: 115 patients were included in the study: 61 with endometrial cancer, 50 with cervical cancer and 4 with ovarian cancer. The surgical procedures performed were: hysterectomy with bilateral salpingo-oophorectomy, radical hysterectomy, pelvic lymphadenectomy, para-aortic lymphadenectomy and omentectomy. All surgical procedures required the introduction of 4 ports, 3 for the robot and 1 for the assistant. With a mean follow-up of 504.4 days (507.7 days for endometrial cancer, 479.5 days for cervical cancer, and 511.3 for ovarian cancer), we observed 9 recurrences but no port-site metastasis.

Conclusion: No port-site metastasis has occurred in our series. However, larger, prospective and randomized works are needed to formally conclude.

Keywords: Pelvic cancer; Port-site metastasis; Robotic surgery.

MeSH terms

  • Abdominal Wall*
  • Adult
  • Aged
  • Aged, 80 and over
  • Aorta
  • Endometrial Neoplasms / pathology
  • Endometrial Neoplasms / surgery*
  • Female
  • Humans
  • Hysterectomy / adverse effects
  • Lymph Node Excision* / adverse effects
  • Middle Aged
  • Neoplasm Seeding*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery*
  • Ovariectomy / adverse effects
  • Pelvis
  • Retrospective Studies
  • Robotic Surgical Procedures / adverse effects*
  • Salpingectomy / adverse effects
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / surgery*